Format

Send to

Choose Destination
Am J Hypertens. 2017 Apr 1;30(4):339-347. doi: 10.1093/ajh/hpw121.

AT2 Receptors: Potential Therapeutic Targets for Hypertension.

Author information

1
Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.

Abstract

The renin-angiotensin system (RAS) is arguably the most important and best studied hormonal system in the control of blood pressure (BP) and the pathogenesis of hypertension. The RAS features its main effector angiotensin II (Ang II) acting via its 2 major receptors, angiotensin type-1(AT1R) and type-2 (AT2R). In general, AT2Rs oppose the detrimental actions of Ang II via AT1Rs. AT2R activation induces vasodilation and natriuresis, but its effects to lower BP in hypertension have not been as clear as anticipated. Recent studies, however, have demonstrated that acute and chronic AT2R stimulation can induce natriuresis and lower BP in the Ang II infusion model of experimental hypertension. AT2R activation induces receptor recruitment from intracellular sites to the apical plasma membranes of renal proximal tubule cells via a bradykinin, nitric oxide, and cyclic guanosine 3',5' monophosphate signaling pathway that results in internalization and inactivation of sodium (Na+) transporters Na+-H+ exchanger-3 and Na+/K+ATPase. These responses do not require the presence of concurrent AT1R blockade and are effective both in the prevention and reversal of hypertension. This review will address the role of AT2Rs in the control of BP and Na+ excretion and the case for these receptors as potential therapeutic targets for hypertension in humans.

KEYWORDS:

AT2 receptor activation; angiotensin II infusion model; angiotensin receptors; antihypertensive agent; blood pressure; cell signaling; experimental hypertension; hypertension; natriuresis; receptor trafficking; sodium excretion; sodium transporters; sodium–hydrogen exchanger-3; sodium–potassium/ATPase; treatment of hypertension.

PMID:
27664954
DOI:
10.1093/ajh/hpw121
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center